Ambev S.A. (ABEV) Downgraded by UBS on Risk/Reward Concerns

Ambev S.A. (NYSE:ABEV) is one of the best low priced stocks to buy right now. Ambev S.A. (NYSE:ABEV) was downgraded to Sell from Neutral by UBS on April 16, with the firm setting a $2.65 price target on the stock. It told investors in a research note that it believes the stock’s risk/reward at current levels to be “skewed to the downside”, following the 32% rally over the past six months. The firm added that there is a “growing disconnect” between Ambev S.A.’s (NYSE:ABEV) earnings growth profile, Brazil’s cost of capital, and valuation.

For additional reference, in its fiscal Q4 and full year 2025 results, Ambev S.A. (NYSE:ABEV) reported that top-line performance was driven by net revenue per hectoliter growth of 8.7% in the quarter. Net revenue for fiscal year 2025 rose by 4.0%, with NR/hl growth of 7.5%, driven primarily by factors such as favorable mix, premiumization, and revenue management initiatives. Management also stated that net revenue rose in most of the company’s operations, including  LAS2 (+15.6%), Brazil NAB (+4.9%), and Canada (+0.8%), while remaining flat in Brazil Beer (0.0%), and declining slightly in CAC (-0.1%).

Ambev S.A. (NYSE:ABEV) produces, distributes, and sells beverages. Its offerings include carbonated soft drinks, beer, and other non-alcoholic and non-carbonated products. The company’s operations are divided into the following geographical segments: Brazil, Central America and the Caribbean (CAC), and Canada.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.